BRIANNA DAVIS: Open Payments
NPI 1548817380 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 23 payments from 13 companies in 2025. Trend: 2023 $141 · 2024 $249 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $133 |
| GENZYME CORPORATION | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Philips North America LLC | 2 | $60 |
| Amgen Inc. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: FABRAZYME, WATCHMAN FLX, LifeVest, EVKEEZA, Ambulatory Monitoring & Diagnostics Undivided, REPATHA, LEQVIO, CARDIOMEMS.
Industry payments across SD — which companies pay providers there.
